Apr 18, 2012
112th Congress, 2011–2013
Died in a previous Congress
This bill was introduced on April 18, 2012, in a previous session of Congress, but was not enacted.
Representative for Maryland's 8th congressional district
Read Text »
Last Updated: Apr 18, 2012
Length: 2 pages
About the bill
To permit manufacturers of generic drugs to provide additional warnings with respect to such drugs in the same manner that the Food and Drug Administration allows brand names to do so.
The bill’s titles are written by its sponsor.
This is the first step in the legislative process.
Links & tools
Click a format for a citation suggestion:
Civic Impulse. (2016). H.R. 4384 — 112th Congress: Patient Safety and Drug Labeling Improvement Act. Retrieved from https://www.govtrack.us/congress/bills/112/hr4384
“H.R. 4384 — 112th Congress: Patient Safety and Drug Labeling Improvement Act.” www.GovTrack.us. 2012. September 29, 2016 <https://www.govtrack.us/congress/bills/112/hr4384>
|title=H.R. 4384 (112th)
|accessdate=September 29, 2016
|author=112th Congress (2012)
|date=April 18, 2012
|quote=Patient Safety and Drug Labeling Improvement Act